Cargando…
HIV/HCV Co-infection: Pathogenesis, Clinical Complications, Treatment, and New Therapeutic Technologies
World-wide, hepatitis C virus (HCV) accounts for approximately 130 million chronic infections, with an overall 3% prevalence. Four to 5 million persons are co-infected with HIV. It is well established that HIV has a negative impact on the natural history of HCV, including a higher rate of viral pers...
Autores principales: | Operskalski, Eva A., Kovacs, Andrea |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Current Science Inc.
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3035774/ https://www.ncbi.nlm.nih.gov/pubmed/21221855 http://dx.doi.org/10.1007/s11904-010-0071-3 |
Ejemplares similares
-
MicroRNAs, Hepatitis C Virus, and HCV/HIV-1 Co-Infection: New Insights in Pathogenesis and Therapy
por: Gupta, Archana, et al.
Publicado: (2012) -
HIV-Specific T-Cells Accumulate in the Liver in HCV/HIV Co-Infection
por: Vali, Bahareh, et al.
Publicado: (2008) -
HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes
por: Garbuglia, Anna Rosa, et al.
Publicado: (2014) -
Superior outcomes in HIV-positive kidney transplant patients compared to HCV-infected or HIV/HCV co-infected recipients
por: Sawinski, Deirdre, et al.
Publicado: (2015) -
Hepatitis C (HCV) therapy for HCV mono-infected and HIV-HCV co-infected individuals living in Nepal
por: KC, Sudhamshu, et al.
Publicado: (2020)